title: Chimpanzees and supporting models in the study of malaria pre-erythrocytic stages.
abstract: Chimpanzees are being used in the study of immune response to Plasmodium falciparum malaria pre-erythrocytic stages (MPES). Responses induced by immunisation with recombinant/synthetic antigens and by irradiated sporozoites are being evaluated in a model system that is phylogenetically close to humans and that is amenable to limited manipulation not possible in humans. The value of chimpanzees for the in-depth study of immunological mechanisms at work in MPES-induced protection are discussed. A total number of 7 chimpanzees have been used to evaluate the immune response to recombinant antigens, and 5 have been challenged with large numbers of sporozoites, followed by surgical liver-wedge resection, in order to generate infected liver tissue for histological and immunological studies. As a complementary model, SCID mice carrying live, transplanted human and primate hepatocytes have been inoculated with sporozoites and infection of transplanted cells has been monitored by histological and immunological methods. In ongoing experiments chimpanzees are being immunised with MPES-derived lipopeptides that have been shown to overcome MHC restriction in mice, and with irradiated sporozoites.
authors.affiliation: Laboratory for Parasitology, Biomedical Primate Research Center-TNO, Rijswijk, The Netherlands.
authors.forename: A W
authors.initials: AW
authors.lastname: Thomas
authors.forename: B
authors.initials: B
authors.lastname: Slierendregt
authors.forename: B
authors.initials: B
authors.lastname: Mons
authors.forename: P
authors.initials: P
authors.lastname: Druilhe
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D004912:Erythrocytes; D006801:Humans; D007114:Immunization; D008288:Malaria / Q000276:immunology*; D002679:Pan troglodytes / Q000469:parasitology*; D010961:Plasmodium / Q000254:growth & development / Q000276:immunology; D014614:Vaccines, Synthetic / Q000008:administration & dosage
chemical_list: D014614:Vaccines, Synthetic